NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

Once again, opinions are just opinions!

Per your comments

"NWBO even identified the clinical PFS from the pseudo-progression. It is an endpoint in the NWBO "new" protocol and SAP == but the clinicians and NWBO are afraid to report it as it may once again reinforce the PFS failure. The naive OS treatment arm was statistically manipulated, so we don't really know the real results -- just NWBO manipulated endpoint - read the SAP filed with the JAMA Oncology manuscript."

So, what, the OS data results stand firm as they should and support NWBO's efforts to move forward.

Per your comments,

"Let's see if Dr. Laiu's boast of 50% survival after 100 months is REAL -- way out of line with any prior clinical evidence for either DCVax-L or Keytruda."
Who is Dr. Laiu, a new research specialist??????

The request was made based on personal comments that I presented regarding Dr. Linda Liau's data results that illustrated a 50% survival after 100 months. Again. personal comments on your part. BTW, it is DCVax-L add with other compounds that support the new results, not just DCVax-L alone. The good news is that Dr. Linda Liau and her team are making great strides. This certainly makes the flux capacitor helmet look tiny in the long run, IMPO.